The Exactech Connexion GXL recipients say their implants are defective and allege the company knew, but never warned them or their surgeons, according to the report. All three plaintiffs say they suffered severe pain, decreased motion and bone and tissue destruction because of early device failure.
All three hip replacement recipients will need corrective surgery, according to the report.
The FDA recalled the device in June 2021 after Exactech told its sales agents there was an increased risk of premature wear, the report said. Before that, Exactech told surgeons that the device had been phased out and replaced by a newer product, but didn’t mention pending recalls, according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.